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Mental retardation/intellectual disability is a devastating neurodevelopmental disorder with serious impact on affected individuals and
their families, as well as on health and social services. It occurs with a prevalence of ~2%, is an etiologically heterogeneous condition, and
is frequently the result of genetic aberrations. Autosomal-recessive forms of nonsyndromic MR (NS-ARMR) are believed to be common,
yet only ﬁve genes have been identiﬁed.We have used homozygosity mapping to search for the gene responsible for NS-ARMR in a large
Pakistani pedigree. Using Affymetrix 5.0 single nucleotide polymorphism (SNP) microarrays, we identiﬁed a 3.2 Mb region on 8q24
with a continuous run of 606 homozygous SNPs shared among all affectedmembers of the family. Additional genotype data frommicro-
satellite markers veriﬁed this, allowing us to calculate a two-point LOD score of 5.18. Within this region, we identiﬁed a truncating
homozygous mutation, R475X, in exon 7 of the gene TRAPPC9. In a second large NS-ARMR/ID family, previously linked to 8q24 in
a study of Iranian families, we identiﬁed a 4 bp deletionwithin exon 14 of TRAPPC9, also segregating with the phenotype and truncating
the protein. This gene encodes NIK- and IKK-b-binding protein (NIBP), which is involved in the NF-kB signaling pathway and directly
interacts with IKK-b and MAP3K14. Brain magnetic resonance imaging of affected individuals indicates the presence of mild cerebral
white matter hypoplasia. Microcephaly is present in some but not all affected individuals. Thus, to our knowledge, this is the sixth
gene for NS-ARMR to be discovered.Mental retardation/intellectual disability (MR/ID) is a neu-
rodevelopmental disorder characterized by low intelli-
gence quotient (IQ) and deﬁcits in adaptive behaviors
that interfere with everyday life and is estimated to affect
1%–3% of the population. A diagnosis of mental retarda-
tion requires an IQ of 70 or below and at least two deﬁcits
in adaptive behaviors, such as delayed language, social
skills, or self-help skills.1 MR can present as the sole clinical
feature (nonsyndromic) or can be present with additional
clinical or dysmorphological features (syndromic). Due to
the high male-to-female ratio, X-linked MR has been
extensively studied, and over 80 causal genes have been
cloned.2,3 However, it is likely that autosomal forms of
MR are more common than X-linked MR, as only ~4% of
genes reside on the X chromosome. Despite this, little is
known about the genetic basis of nonsyndromic auto-
somal-recessive mental retardation (NS-ARMR).
To date, only ﬁve genes have been identiﬁed for NS-
ARMR. These include PRSS12 (MIM 606709), CRBN (MIM
609262), CC2D1A (MIM 610055), GRIK2 (MIM 138244),
and TUSC3 (MIM 601385). These genes have a variety offunctions and participate in multiple biochemical path-
ways. In addition, there are several known disease loci for
NS-ARMR for which genes have not yet been identiﬁed.4
In the present study, a family from the Abbottabad area
in the North-West Frontier Province of Pakistan was
recruited through COMSATS Institute of Information
Technology (Islamabad, Pakistan) after informed written
consent was given (for affected individuals and children
16 or under, parental consent was given). Institutional
research ethics board consent was given for the study
through COMSATS and through the Centre for Addiction
and Mental Health (Toronto). This family has seven living
and one deceased affected members, across three genera-
tions and three branches, where almost all marriages are
between ﬁrst cousins (Figure 1). Six of the affected individ-
uals are female, and one is male. In addition, an affected
female from the grandparental generation (III:4) is now
deceased. Informed written consent was obtained for
each participating family member.
The assessment of level ofMR in the Pakistani family was
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(Figure 1) by a team of three experienced clinicians who
come from the same culture and speak the local language
of the family. The 3-year-old girl (V:9) did not walk inde-
pendently and spoke fewer than 20 meaningful words.
She could not feed herself and had not achieved conti-
nence during the day or night. No seizures were reported.
The 6-year-old female (V:8) started walking at 4 years of
age. She did not use full sentences. She was overweight
but not obese (weight, 38 Kg; height, 116 cm; BMI, 28.2)
and is reported to have clonic/tonic seizures, for which
neuroleptic treatment has started. The 9-year-old male
(V:3) started walking at 5 years of age. He was able to ask
for food, but was unable to feed himself. He was able to
convey the need to go to the toilet, but needed help with
washing and cleaning. Mild kyphosis was observed, but
no seizures were reported.
Although fully standardized IQ testing was not possible
due to cultural and linguistic barriers, all affected individ-
uals were assessed using the Vineland Adaptive Behavior
Scales, Second Edition5 and Portage Guide to Early
Intervention6 as the framework for the assessment. The
information gathered was discussed within the team of
clinicians, and consensus diagnoses of moderate to severe
MR/ID were reached based on DSM IV criteria.1 Develop-
mental trajectories did not differ between the affected
individuals, and the degree of disability was similar across
all the domains of functioning. No clinical features to indi-
cate the presence of Autism Spectrum Disorder or mental
illness (other than MR/ID) were present. They typically
Table 1. Occipitofrontal Head Circumference Measurements
for Affected Members from Family MR-2019
Pedigree ID Status Sex Age OFC (cm) OFC SD.
V:3 Affected M 9 49 2.5
V:4 Affected F 11 50.5 5th centile
V:7 Affected F 14 54 normal
V:8 Affected F 6 49 5th centile
V:9 Affected F 3 46.5 2
lV:9 Affected F 34 not available not available
lV:10 Affected F 30 52 2
Approximate percentile is given, or if below fifth centile, approximate number
of SDs below the mean is given, according to normative values provided
by Nellhaus9 and Roche et al.20 Ages given are estimated from birth year.
M, male; F, female.started to walk at 5 years of age. In spite of the availability
of the opportunity, none of the affected individuals had
acquired the ability to read and write.
Photographs of the affected individuals were examined
for dysmorphic features by an experienced clinical geneti-
cist (R.W.). Neurological assessment was performed by a
consultant neurologist (M. Azam) trained in the UK and
currently working in Islamabad. He performed a thorough
physical and neurological clinical examination of patients
V:3, V:8, and V:9, including structural magnetic resonance
imaging (MRI), with multiplanar imaging done through
T1/T2WI sagittal, axial, and coronal sequences. Blood
biochemistry was tested at the Islamabad Diagnostic
Centre, including testing for liver function, renal function,
electrolytes, and hematology.
Assessment for dysmorphological features proved nega-
tive, save that measurement of occipitofrontal head
circumference (OFC) was low, at around the ﬁfth centile,
for two affected girls, but borderline microcephaly for
three others (2–3 SDs below the mean) and normal for
one female (V:7) (Table 1). The height and weight were
within normal range for the local population. Neurological
examination was normal in all affected individuals. The
size of the spleen and liver were also normal, and there
were no cardiac or respiratory abnormalities. Blood hema-
tology and biochemistry markers were within the normal
range, except creatine phospokinase levels were elevated
(V:3, 218 U/l; V:8, 227 U/l; V:9, 402 U/l).
MRI analysis on three affected individuals (V:3, V:8, and
V:9) (Figure 1) showed diminished cerebral white matter
volume, with sulcal enlargement, thinning of the corpus
callosum, and mildly reduced cerebellar volume (Figures
1B–1D). In addition, several areas of T2 hyperintensity
were present in the subcortical white matter (Figure 1D).
The overall interpretation of theMRI scans was diminished
volume of the supra- and infratentorial cortex and under-
lying white matter. Although this likely represents cortical
atrophy with secondary degeneration of white matter,
serial imaging showing progressive volume loss would be
required to prove atrophy.
DNA from seven affected family members and one unaf-
fected family member was analyzed using Affymetrix
Genome-Wide Human single nucleotide polymorphism
(SNP) Array 5.0 (Affymetrix; Santa Clara, CA). Microarray
analysis was performed at the London Regional Genomics
Centre (LRGC) (University of Western Ontario; London,
ON, Canada). The data were then analyzed using dChipFigure 1. Pedigrees of Families and MRI Images
(A) Pedigree and MRI images for family MR-2019 are shown in (A–E). Pedigree for MR-2019 (A): affected individuals are connected
by loops of consanguinity over ﬁve generations.
(B) MRI image from female affected V:9: sagittal T1-weighted image showing thin corpus callosum and a small cerebellar vermis
with prominent folia. The brain stem is also diffusely thin.
(C) MRI image from female affected V:8: coronal T2-weighted image showing enlarged CSF spaces, suggesting cortical volume loss.
(D) MRI images from female affected V:9: axial T2-weighted image showing areas of T2 hyperintensity in subcortical white matter
(arrowhead), enlarged sulci, and reduced white matter volume compatible with mildly diminished cerebral cortical and white matter
volume.
(E) Pedigree for M001: affected individuals are connected by loops of consanguinity over ﬁve generations.
The American Journal of Human Genetics 85, 909–915, December 11, 2009 911
software for extended runs of homozygosity. We identiﬁed
a 3.2Mb region of autozygosity in the family at locus 8q24,
from 139,465,102 to 142,726,810 (UCSC Genome
Browser), consisting of a run of 606 consecutive homozy-
gous SNPs. This region overlaps with a 6.8 Mb locus iden-
tiﬁed in an Iranian NS-ARMR pedigree.4 After conﬁrming
autozygosity between affected members, microsatellite
genotype analysis was performed for all participating
Figure 2. Disease Locus and TRAPPC9
Mutation
(A) Shared homozygous region in Family
MR-2019 on chromosome 8q24.23–q24.3.
(B) Electropherograms for MR-2019
indicate the sequence change in exon 7,
with wild-type, heterozygous carrier, and
homozygous affected, leading to the
amino acid change: Arginine 475 Stop.
(C) Electropherograms for M001 indicate
a four base pair deletion in exon 14, result-
ing in a frameshift mutation that leads
to the mutation p.Leu772TrpfsX7 and
truncates the protein at residue 779.
family members. The microsatellite
markers used were D8S256, D8S1837,
D8S1743, and D8S1704.
The 3.2 Mb region contains 12
genes, only one of which has been
previously implicated in MR. This
gene, KCNK9 (MIM 605874), has
been shown to be causal in recently
identiﬁed Birk-Barel Syndrome7
(MIM 612292). We excluded KCNK9
by direct sequencing. To select candi-
date MR genes in the locus, we looked
for genes that are expressed at high
levels in the brain or that function
in neurogenesis and development.
We also used the UGET algorithm,
which uses banked Affymetrix gene-
chip data to identify genes within
the autozygous region that showed
high correlation of expression with
known disease genes.8 All primers
used were designed using the Primer3
program. PCR reactions were per-
formed under standard conditions.
We sequenced the selected candidate
genes, namely PTK2 [MIM 600758]
and TRAPPC9 (NIBP [MIM 611966]).
We identiﬁed the nucleotide sub-
stitution c.1422C / T in exon 7 of
TRAPPC9 (GenBank Accession
#NM_031466), which results in the
nonsense mutation R475X (Figure 2).
The mutation is inherited in an
autosomal-recessive fashion: all
parents of affected members are
heterozygous for the mutation, and all family members
who are homozygous for the mutation express the pheno-
type. We screened 290 Pakistani controls (580 chromo-
somes) for the mutation by PCR ampliﬁcation of exon 7
followed by TaqI restriction endonuclease. The TaqI cut
site is destroyed by the mutation, so normal individuals
should show digested PCR product on agarose gel. None
of the controls had the mutated allele. Two-point912 The American Journal of Human Genetics 85, 909–915, December 11, 2009
parametric linkage analysis using easyLINKAGE Plus v5.02
gave a LOD score of 5.18 for marker D8S1704, situated at
chr8:141,720,577–141,720,617 (UCSC hg18).
To assess the effect of this mutation on expression, we
performed a quantitative RT-PCR experiment. This anal-
ysis of TRAPPC9 cDNA was performed using lymphoblast
cDNA from two affected individuals from the family (V:3
and V:7) and three unrelated healthy controls, with the
gene HPRT [MIM 308000] as the internal control house-
keeping gene. Primers for the real-time PCR experiment
were designed to include the end of TRAPPC9 exon 2
and the beginning of exon 3, thus spanning the second
intron of the gene. We used SYBR Green Dye I chemistry
(4309155, Applied Biosystems; Carlsbad, CA) using the
Applied Biosystems 7300 Real-Time PCR System. The rela-
tive standard curvemethod was used to analyze the expres-
sion of TRAPPC9 in affected individuals and controls, and
the experimental data were analyzed with the 7500 Soft-
ware v2.0.1. Results indicated that, in individuals homozy-
gous for 475X, the TRAPPC9 mRNA is expressed at only a
fraction of the amount for controls with wild-type 475R
(Figure 3). This suggests that the mutation results in
a signiﬁcant degree of nonsense-mediated mRNA decay,
and hence, if there is any residual function in the trun-
cated NIK- and IKK-b-binding protein (NIBP), expression
levels would be very low.
We obtained DNA from family members of the Iranian
pedigree M001 from the Najmabadi et al. study.4 This large
NS-ARMR family mapped to a 6.8 Mb critical interval on
8q24 that included TRAPPC9. Sequence analysis identiﬁed
a 4 bp deletion: c.2311–2314 delTGTT, resulting in frame-
Figure 3. qPCR Assay of TRAPPC9 mRNA
Quantitative measurement of TRAPPC9 mRNA from lympho-
blasts, measured using real-time PCR. The level of expression
between individuals carrying a mutation in TRAPPC9 and those
with the wild-type gene is clearly different, suggesting nonsense-
mediated mRNA decay associated with the mutation. Subjects
C1 and C2 are age- and sex-matched healthy controls. Affected
individuals are V:7 and V:3. mRNA levels were normalized against
the housekeeping gene HPRT1. Error bars indicate maximum and
minimum values.The Americanshift and premature truncation: p.Leu772TrpfsX7. This
deletion segregates in a recessive manner in the family.
Affected members of this family have severe NS-ARMR/ID
and are ambulatory but nonverbal, with no history of
seizures and no dysmorphic or unusual facial features.
OFC head size was measured in three adult male affected
individuals, aged 27, 33, and 37 years, as 54, 53, and
52.5 cm, respectively (between 1 and3 SDbelow themean).
We have identiﬁed a gene for autosomal-recessive
mental retardation, TRAPPC9, by autozygosity mapping
in a large consanguineous Pakistani family, with conﬁrma-
tion in an Iranian family. In the Pakistani family, although
the phenotype appears to be nonsyndromicMR, mild cere-
bral white matter hypoplasia and small head circumfer-
ence are present in most of the patients (Table 1). These
head sizes, in comparison to age/sex means,9 would not
be classiﬁed as true microcephaly, for which OFC would
be >4 SD below the mean (see review by Woods et al.).10
The head growth trajectories for these subjects is not avail-
able; thus, it cannot be determined whether head size
developed normally up to a certain age and then growth
slowed or whether head growth was delayed from birth.
The relevance of these clinical features to TRAPPC9 muta-
tions can be conﬁrmed only through the identiﬁcation
and evaluation of additional families.
TRAPPC9 is a 23 exon gene that encodes the 1148–1246
amino acid protein, NIBP. NIBP is highly conserved across
evolution (protein sequence identity between human and
mouse, 92%; chicken, 87%; zebraﬁsh, 85%; pufferﬁsh,
75%; sea urchin, 42%; bee, 35%); however, no known
functional domains are present. COILS predicts the pres-
ence of coiled coil from amino acid residue 1062–1076.
PSORT II predicts no signal peptides, no nuclear or organ-
elle targeting sequences, and no ER retention signals and
predicts NIBP to be a cytoplasmic protein.
NIBP contains one known conserved region, originally
identiﬁed in Saccharomyces cerevisiae, called Trs120.11 It is
believed to function as part of a large multisubunit teth-
ering complex, TRAPPII, trafﬁcking vesicles/proteins from
the Golgi to the plasma membrane.11,12 Mutants of
Trs120 in yeast cause defective trafﬁcking from early endo-
some to late Golgi, suggesting a role for TRAPPII in sorting/
recycling of proteins from the plasma membrane.13
In humans, multiple NIBP isoforms are expressed at high
levels in themuscle and kidney and to a lesser extent in the
brain, heart, and placenta.14 Only isoform 1 is present in
the brain, where it is expressed in the cell bodies and
processes of neurons.14 Knockdown of NIBP has been
shown to reduce TNFa-induced NF-kB activation, prevent
nerve growth factor-induced neuronal differentiation,
and decrease Bcl-xL gene expression in PC12 cells.14 We
speculate that the loss of NIBP function through trun-
cating mutations in the Pakistani and Iranian families
presented here might cause disruption of neuronal differ-
entiation, which could result in the cerebral white matter
hypoplasia observed throughMRI. NIBP also directly inter-
acts with IKK-b and MAP3K14 and is involved in bothJournal of Human Genetics 85, 909–915, December 11, 2009 913
classical and alternative activation of the NF-kB signaling
pathway.14
The activity of TRAPPC9/NIBP in the NF-kB pathway14 is
of interest because another gene involved innonsyndromic
MR/ID,CC2D1A, was identiﬁed as an activator of theNF-kB
signaling pathway,15 suggesting that disruption of this
pathway might also be relevant to the etiology of MR/ID.
Identifying the genetic cause of MR in an individual or
family could have signiﬁcant beneﬁts. For some genetic
forms of MR, a simple metabolic therapy could be readily
available, whereas for others, treatment could be antici-
pated in the near future. Additional beneﬁts include antic-
ipating comorbid medical problems and assisting with
family planning. Also, in families where consanguineous
marriages are practiced, this information might be used
to advise the family how to prevent the disease recurring
by avoiding marriage between mutation carriers.16
The identiﬁcation of a mutation that eliminates NIBP—
a component of the TRAPPII trafﬁcking complex—suggests
a potentially novel pathway involved in the brain dysfunc-
tion underlying MR. It is of interest that TRAPPC10, which
encodes the human ortholog of the TRAPPII component
Trs130, has been implicated in holoprosencephaly with
epilepsy.17 Another TRAPP component, synbindin, en-
coded by TRAPPC4 (MIM 610971), binds with syndecan-
2 (encoded by SDC2 [MIM 142460]) in neuronal dendritic
spines.18 SDC2 has previously been identiﬁed at the 8q22.1
breakpoint of a translocation t(X;8)(p22.13;q22.1) in a
patient with autism and multiple exostoses,19 and SDC2
transcription might be dysregulated by position effect.
We speculate that mutations in other components of the
TRAPPII complex that function in neurons might also
cause NS-ARMR or other neuropsychiatric phenotypes.
Indeed, several other components of vesicular trafﬁcking
pathways are already known to be associated with MR/
ID, including VPS13B (Cohen syndrome; MIM 607817),
GDI1 (NS-XLMR; MIM 300104), and GAP/TSC2 (tuberous
sclerosis 2; MIM 191092).
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